BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld
BioWorld
May 3, 2002
View Archived Issues
AVI Starting Avicine Phase III To Speed Approval Timeline
AVI BioPharma Inc. changed the course for its lead anticancer product, the vaccine Avicine, in an effort to shorten the route toward a possible FDA approval. (BioWorld Today)
Read More
Syrrx Enters Deal To Provide Roche With Protein Structures
Read More
Demyelination Is Mycobacterium leprae’s Nerve Killer In Infectious And Neurodegenerative Diseases
Read More
Nyxis Getting Ready To Move Glyxins Family Into The Clinic
Read More
Other News To Note
Read More
Quarterly Earnings Reports
Read More